Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Long-Term Debt Repayments: 2018

Historic Long-Term Debt Repayments for Aclaris Therapeutics (ACRS) over the last 1 years, with Dec 2018 value amounting to $149,000.

  • Aclaris Therapeutics' Long-Term Debt Repayments was N/A to $149,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $648,000, marking a year-over-year change of. This contributed to the annual value of -$11.5 million for FY2021, which is N/A change from last year.
  • Per Aclaris Therapeutics' latest filing, its Long-Term Debt Repayments stood at $149,000 for Q4 2018, which was down 9.15% from $164,000 recorded in Q3 2018.
  • In the past 5 years, Aclaris Therapeutics' Long-Term Debt Repayments ranged from a high of $299,000 in Q2 2018 and a low of $36,000 during Q1 2018.
  • Moreover, its 1-year median value for Long-Term Debt Repayments was $156,500 (2018), whereas its average is $162,000.